Literature DB >> 18067553

Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO.

Charlotte A Williams1, Rachel A Harry, Julie D McLeod.   

Abstract

Dendritic cells (DC) are sensitive to their local environment and are affected by proximal cell death. This study investigated the modulatory effect of cell death on DC function. Monocyte-derived DC exposed to apoptotic Jurkat or primary T cells failed to induce phenotypic maturation of the DC and were unable to support CD4+ allogeneic T-cell proliferation compared with DC exposed to lipopolysaccharide (LPS) or necrotic cells. Apoptotic cells coincubated with LPS- or necrotic cell-induced mature DC significantly suppressed CD80, CD86 and CD83 and attenuated LPS-induced CD4+ T-cell proliferation. Reduced levels of interleukin-12 (IL-12), IL-10, IL-6, tumour necrosis factor-alpha and interferon-gamma (IFN-gamma) were found to be concomitant with the suppressive activity of apoptotic cells upon DC. Furthermore, intracellular staining confirmed IFN-gamma expression by DC in association with apoptotic environments. The specific generation of IFN-gamma by DC within apoptotic environments is suggestive of an anti-inflammatory role by the induction of indoleamine 2,3-dioxygenase (IDO). Both neutralization of IFN-gamma and IDO blockade demonstrated a role for IFN-gamma and IDO in the suppression of CD4+ T cells. Moreover, we demonstrate that IDO expression within the DC was found to be IFN-gamma-dependent. Blocking transforming growth factor-beta (TGF-beta) also produced a partial release in T-cell proliferation. Our study strongly suggests that apoptosis-induced DC suppression is not an immunological null event and two prime mediators underpinning these functional effects are IFN-gamma-induced IDO and TGF-beta.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18067553      PMCID: PMC2434374          DOI: 10.1111/j.1365-2567.2007.02743.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  61 in total

Review 1.  A blast from the past: clearance of apoptotic cells regulates immune responses.

Authors:  John Savill; Ian Dransfield; Chris Gregory; Chris Haslett
Journal:  Nat Rev Immunol       Date:  2002-12       Impact factor: 53.106

Review 2.  Tolerance, DCs and tryptophan: much ado about IDO.

Authors:  Ursula Grohmann; Francesca Fallarino; Paolo Puccetti
Journal:  Trends Immunol       Date:  2003-05       Impact factor: 16.687

3.  Autologous apoptotic T cells interact with dendritic cells, but do not affect their surface phenotype or their ability to induce recall immune responses.

Authors:  P J Newton; I V D Weller; D R Katz; B M Chain
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

4.  Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

Authors:  Manfred B Lutz; Gerold Schuler
Journal:  Trends Immunol       Date:  2002-09       Impact factor: 16.687

5.  The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function.

Authors:  Mojca Skoberne; Selin Somersan; Wanda Almodovar; Tuan Truong; Kseniya Petrova; Peter M Henson; Nina Bhardwaj
Journal:  Blood       Date:  2006-04-13       Impact factor: 22.113

6.  Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells.

Authors:  G Pietra; R Mortarini; G Parmiani; A Anichini
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

7.  T cell apoptosis by tryptophan catabolism.

Authors:  F Fallarino; U Grohmann; C Vacca; R Bianchi; C Orabona; A Spreca; M C Fioretti; P Puccetti
Journal:  Cell Death Differ       Date:  2002-10       Impact factor: 15.828

8.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

9.  CTLA-4-Ig regulates tryptophan catabolism in vivo.

Authors:  Ursula Grohmann; Ciriana Orabona; Francesca Fallarino; Carmine Vacca; Filippo Calcinaro; Alberto Falorni; Paola Candeloro; Maria L Belladonna; Roberta Bianchi; Maria C Fioretti; Paolo Puccetti
Journal:  Nat Immunol       Date:  2002-09-30       Impact factor: 25.606

10.  Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production.

Authors:  Adrian E Morelli; Adriana T Larregina; William J Shufesky; Alan F Zahorchak; Alison J Logar; Glenn D Papworth; Zhiliang Wang; Simon C Watkins; Louis D Falo; Angus W Thomson
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

View more
  30 in total

1.  Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.

Authors:  Rachel A Reboulet; Cassandra M Hennies; Zacarias Garcia; Stefan Nierkens; Edith M Janssen
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

2.  Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg.

Authors:  Rahul Kushwah; Jing Wu; Jordan R Oliver; George Jiang; Jinyi Zhang; Katherine A Siminovitch; Jim Hu
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

3.  Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.

Authors:  C M Hennies; R A Reboulet; Z Garcia; S Nierkens; M C Wolkers; E M Janssen
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

Review 4.  Breaking T cell tolerance to beta cell antigens by merocytic dendritic cells.

Authors:  Jonathan D Katz; Edith M Janssen
Journal:  Cell Mol Life Sci       Date:  2011-05-31       Impact factor: 9.261

5.  Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury.

Authors:  Amandeep Bajwa; Liping Huang; Elvira Kurmaeva; Joseph C Gigliotti; Hong Ye; Jacqueline Miller; Diane L Rosin; Peter I Lobo; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 10.121

Review 6.  Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells.

Authors:  Adrian E Morelli; Adriana T Larregina
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

Review 7.  O death where is thy sting? Immunologic tolerance to apoptotic self.

Authors:  Buvana Ravishankar; Tracy L McGaha
Journal:  Cell Mol Life Sci       Date:  2013-02-03       Impact factor: 9.261

8.  C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells.

Authors:  Deborah A Fraser; Amanda K Laust; Edward L Nelson; Andrea J Tenner
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

9.  Activation-induced CD154 expression abrogates tolerance induced by apoptotic cells.

Authors:  Prajwal Gurung; Tamara A Kucaba; Thomas A Ferguson; Thomas S Griffith
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

10.  Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes.

Authors:  Peng Liu; Bai-Lu Xie; Shao-Hui Cai; Yun-Wen He; Ge Zhang; Yan-Mei Yi; Jun Du
Journal:  BMC Cancer       Date:  2009-11-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.